First Surgical Case Using K2M’s Capri Corpectomy Cage System Completed

Leesburg, Va.-based K2M Group Holdings Inc., a medical device company focused complex spine technologies, techniques and minimally invasive procedures, has announced the completion of the first surgical case using its Capri corpectomy cage system, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy. The first surgical case was performed by Stefano Boriani, M.D., at Rizzoli Hospital in Bologna, Italy.

“The Capri Corpectomy Cage offers surgeons a truly innovative cage system that is designed to allow for continuous height expansion and endplate angulation,” said Dr. Boriani. “Due to this unique design and functionality, I was able to adjust the cage in-situ to engage the patient’s inferior and superior vertebral body endplates. I am very pleased with the design, functionality and ease of use.”

The Capri system is intended for use in the thoracolumbar spine (T1 to L5) to replace collapsed, damaged or unstable vertebral bodies due to tumor or trauma (i.e., fracture). It is designed to provide anterior spinal column support even in the absence of fusion for a prolonged period.

Capri cages, manufactured from titanium and cobalt chrome, are offered in a variety of interchangeable footprint options, allowing for in-situ height expansion and endplate angulation to match the patient’s anatomy. Additionally, the device may be implanted through an anterior, lateral or posterior approach.

“We are pleased to announce the successful completion of the first surgical case using Capri,” said Eric Major, K2M’s president and CEO. “This milestone reinforces K2M’s commitment to establishing ourselves as the global leader in providing solutions for complex spinal pathologies.”

K2M received 510(k) clearance for Capri from the U.S. Food and Drug Administration (FDA) in November. The company also recently received the CE mark to market Capri in the European Union.